| Q46576659 | A randomized study of the effects of preoperative ketorolac on general anaesthesia for caesarean section. |
| Q40300755 | A successful antenatal myomectomy |
| Q35064290 | An update on the controversies of tocolytic therapy for the prevention of preterm birth |
| Q28218219 | Anti-inflammatory and immunosuppressive drugs and reproduction |
| Q58767786 | Are complicated monochorionic twins more susceptible to indomethacin-induced fetal ductal constriction? Two cases of laser surgery for Twin-Twin Transfusion syndrome |
| Q28554873 | Association of Prenatal Ibuprofen Exposure with Birth Weight and Gestational Age: A Population-Based Sibling Study |
| Q34303482 | Comparative tolerability of pharmacological treatments for patent ductus arteriosus |
| Q36695955 | Current Perspectives on Pathobiology of the Ductus Arteriosus |
| Q24198274 | Cyclo-oxygenase (COX) inhibitors for preventing preterm labour |
| Q34777113 | Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus |
| Q35064612 | Efficacy of paracetamol on patent ductus arteriosus closure may be dose dependent: evidence from human and murine studies. |
| Q44941545 | Experience of the use of nimesulide, a cyclo-oxygenase-2 selective prostaglandin synthesis inhibitor, in the prevention of preterm labour in 44 high-risk cases |
| Q34644135 | Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. |
| Q31044246 | Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data |
| Q46329956 | Idiopathic severe constriction of the fetal ductus arteriosus: a possible underestimated pathophysiology |
| Q44675543 | In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal renal failure |
| Q54936005 | Indomethacin induced ductus arteriosus closure in midgestation fetus. |
| Q47304334 | Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants? |
| Q33644543 | Inhibition of cyclooxygenase isoforms in late- but not midgestation decreases contractility of the ductus arteriosus and prevents postnatal closure in mice |
| Q34010770 | Management of preterm labour |
| Q33710361 | Maternal consumption of polyphenol-rich foods in late pregnancy and fetal ductus arteriosus flow dynamics. |
| Q38032732 | Maternal diclofenac medication in pregnancy causing in utero closure of the fetal ductus arteriosus and hydrops |
| Q36105461 | Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn |
| Q43063871 | Pharmacological treatment of migraine during pregnancy and breastfeeding |
| Q41634730 | Prenatal constriction of the ductus arteriosus following maternal diclofenac medication in the third trimester |
| Q33785391 | Prenatal effects of maternal consumption of polyphenol-rich foods in late pregnancy upon fetal ductus arteriosus |
| Q33330631 | Recent indomethacin tocolysis is not associated with neonatal complications in preterm infants |
| Q35040619 | Reproductive considerations: mare and stallion |
| Q82267192 | Reversible ductus arteriosus constriction due to maternal indomethacin after fetal intervention for hypoplastic left heart syndrome with intact/restrictive atrial septum |
| Q36866623 | Spontaneous Rhythmic Contractions (Vasomotion) of the Isolated, Pressurized Ductus Arteriosus of Preterm, but Not Term, Fetal Mice |
| Q81944352 | Spontaneous prenatal ductal closure: postnatal diagnosis? |
| Q33973168 | Systematic review: is the use of NSAIDs safe during pregnancy in women with rheumatic disease? |
| Q47316789 | The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants |
| Q30820136 | Uterus-targeted liposomes for preterm labor management: studies in pregnant mice |
| Q83277626 | [Antirheumatic therapy and reproduction. The influence on fertility, pregnancy and breast feeding] |
| Q83217510 | [Drug therapy during pregnancy and breast feeding. Updated summary] |